
Curasight Investor Relations Material
Latest events

Investor Update
Curasight
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Curasight
Access all reports
Curasight is a clinical stage biopharmaceutical company dedicated to developing uPAR Theranostics for the early detection, diagnosis and treatment of cancer. The company's mission is to make a global impact by harnessing imaging technology that improves diagnosis and correlates to improved long-term patient outcome.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
CURAS
Country
🇩🇰 Denmark